C

Camford Capital

6 employees

Camford Capital is a venture capital firm that invests in Enterprise, Consumer, FinTech, and Healthcare companies.

Investor insights

Sectors invested in

Biotechnology7
Health Care4
Life Science3
Therapeutics3
Artificial Intelligence2
Health Diagnostics1
Blockchain1
Product Research1
Medical1
Biopharma1
Pharmaceutical1
Immuno-Oncology1
Immunotherapy1
biotechnology1
synthetic biology1
RNA therapeutics1

Funding rounds participated in

$35M sweet spot round size

Most of their 8 investments are in rounds between $12M and $40M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Consumer Internet
Enterprise Software
Fintech
Biotech
FinTech
Digital Health
Blockchain
Venture Capital

Investments made

S

SURGE Therapeutics raised $32M on July 19, 2023

Investors: Bioluminescence Ventures, Piedmont Capital, 8VC, Alumni Ventures Group, Cancer Research Institute (CRI), Khosla Ventures, Pitango Venture Capital, Intuitive Ventures, KdT Ventures and Camford Capital

L

Lavita raised $5M on May 10, 2023

Investors: Camford Capital

V

Vevo Therapeutics raised $12M on December 8, 2022

Investors: General Catalyst, AIX Ventures and Camford Capital

S

SURGE Therapeutics raised $26M on October 17, 2022

Investors: Intuitive Ventures, Cancer Research Institute (CRI), 8VC, Khosla Ventures, Nirup Clinical Research, Pitango Venture Capital, Alumni Ventures Group and Camford Capital

C

Carbon Biosciences raised $38M on June 21, 2022

Investors: Astellas Venture Capital L.L.C., Longwood Fund, UTokyo Innovation Platform Co., Ltd., Solasta Ventures, Agent Capital and Camford Capital

T

Totus Medicines raised $40M on December 9, 2021

Investors: Northpond Ventures, DCVC Bio and Camford Capital

S

Strand Therapeutics raised $52M on June 23, 2021

Investors: Redmile Group, BeiGene, Playground Global, ANRI and Camford Capital

C

CG Oncology raised $47M on December 10, 2020

Investors: Perseverance Capital Management, ORI Capital Limited, Kissei Pharmaceutical Co Ltd and Camford Capital

FAQ